23 November 2014
: Case report
Spontaneous Hemarthrosis Following Fibrinolytic Therapy for Acute Myocardial Infarction: A Case Report and Literature Review
Unusual clinical course, Diagnostic / therapeutic accidents, Management of emergency care, Adverse events of drug therapy
Mahmoud M. RamadanABDEF, Iqbal S. KhanB, Ousama MahdiDDOI: 10.12659/AJCR.892138
Am J Case Rep 2014; 15:514-517
Abstract
BACKGROUND: Despite the widespread use of fibrinolytic therapy and the numerous reports on its bleeding complications, spontaneous hemarthrosis following fibrinolytic therapy is quite rare.
CASE REPORT: We describe in this report a patient with no previous history of articular disease who developed a spontaneous right knee bloody effusion following fibrinolytic therapy using rt-PA for acute ST-elevation myocardial infarction. Furthermore, we provide a review of all cases of spontaneous hemarthrosis documented so far in the literature.
CONCLUSIONS: Several pre-existing joint diseases may predispose to hemarthrosis following fibrinolytic therapy, even in patients who deny previous or current articular disorders. Therefore, hemorrhage should be considered in the differential diagnosis of mono-arthritis following fibrinolytic therapy for STEMI.
Keywords: Fibrinolytic Agents - therapeutic use, Hemarthrosis - diagnosis, Myocardial Infarction - drug therapy, Thrombolytic Therapy - adverse effects, Tissue Plasminogen Activator - therapeutic use
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946956
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946875
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947289
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946614
Most Viewed Current Articles
21 Jun 2024 : Case report
95,940
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,046
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
30,832
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,344
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030